CJC-1295 + Ipamorelin stack [5mg/5mg]
The CJC-1295 + Ipamorelin is a peptide combination commonly studied for its interaction with growth hormone signalling pathways.
Researchers are interested in this peptide pair because the two compounds act on different biological mechanisms that influence growth hormone release.
CJC-1295 is studied for its ability to interact with growth hormone releasing hormone (GHRH) pathways, while Ipamorelin is researched for its interaction with ghrelin receptors.
When studied together, researchers investigate how these peptides may influence growth hormone pulsatility, metabolic signalling and recovery pathways.
Each vial contains 5mg CJC-1295 and 5mg Ipamorelin, supplied as high-purity lyophilised powder for laboratory and research applications.
Suitable For Research On
• growth hormone signalling pathways
• GHRH receptor research
• ghrelin receptor signalling
• metabolic regulation pathways
• recovery and tissue repair studies
• body composition research
Why Researchers Choose This Stack
Two complementary research peptides
Investigated for growth hormone pathway signalling
Lyophilised powder for stability
High purity research-grade compound
Secure shipping across Australia
Key Research Areas
Growth Hormone Signalling
CJC-1295 is commonly studied for its interaction with growth hormone releasing hormone pathways, which regulate the release of growth hormone from the pituitary gland.
Ghrelin Receptor Activity
Ipamorelin is researched for its interaction with ghrelin receptors, which are involved in appetite signalling and growth hormone release.
Combined Peptide Research
Researchers frequently study the combination to observe how two different signalling pathways may influence growth hormone pulsatility and metabolic regulation.
Storage
Store refrigerated at 2–8°C
Protect from light exposure
Avoid repeated freeze-thaw cycles
Important Notice
This product is sold for laboratory research purposes only.
Not for human consumption.
Not intended to diagnose, treat, cure, or prevent any disease.